• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acute lower limb ischemia: determinants of outcome.

作者信息

Ouriel K, Veith F J

机构信息

Department of Surgery, University of Rochester, NY 14642, USA.

出版信息

Surgery. 1998 Aug;124(2):336-41; discussion 341-2.

PMID:9706157
Abstract

BACKGROUND

Previous studies have documented high rates of morbidity and death after acute peripheral arterial occlusion. To date, however, few studies have identified parameters predictive of successful therapy.

METHODS

The Thrombolysis or Peripheral Arterial Surgery Trial of intraarterial recombinant urokinase or immediate operation for acute lower extremity arterial occlusion provided data on 544 patients randomized at 113 centers. A Cox proportional hazards multifactor analysis was performed to identify those main effects predictive of amputation-free survival and to document any baseline variables useful in deciding whether a patient would be treated best initially with thrombolysis or operation.

RESULTS

Of 28 variables analyzed, eight main effects were predictive of amputation-free survival. These included two demographic factors: white race (risk ratio [RR] = 1.75; p = 0.003) and younger age (RR = 1.015; p = 0.046). Comorbidities comprised four of the main effects: history of central nervous system disease (RR = 1.726; p = 0.005), history of malignancy (RR = 1.615; p = 0.024), congestive heart failure (RR = 2.202; p < 0.001), or low body weight (RR = 1.007 per pound; p = 0.006). The severity of the process was also predictive, as gauged by the presence of skin color changes (RR = 1.585, p = 0.007) or pain at rest (RR = 0.503; p = 0.003). All eight effects were similar in the two treatment groups; none of these variables predicted improved outcome with one form of initial therapy over the other (i.e., there was no therapy-by-variable interaction). The length of occlusion, however, predicted whether a patient would fare better with thrombolysis or operation. With a threshold occlusion length of 30 cm, the RR for longer occlusions to shorter occlusions was 43% better in patients who received thrombolysis, whereas the situation was reversed for those who were randomized to operation.

CONCLUSIONS

A variety of baseline variables can be identified that are predictive of outcome after treatment for acute lower extremity ischemia. In addition, the length of the occlusive process appears to predict whether a patient will be best served with thrombolysis or operative intervention; longer occlusions appear to respond best with an initial thrombolytic strategy.

摘要

相似文献

1
Acute lower limb ischemia: determinants of outcome.
Surgery. 1998 Aug;124(2):336-41; discussion 341-2.
2
When is urokinase treatment an effective sole or adjunctive treatment for acute limb ischemia secondary to native artery occlusion?对于由天然动脉闭塞继发的急性肢体缺血,尿激酶治疗何时是一种有效的单一或辅助治疗方法?
Am J Surg. 1999 Aug;178(2):103-6. doi: 10.1016/s0002-9610(99)00135-x.
3
Randomized comparison of thrombolysis and surgery. TOPAS Investigators. Thrombolysis or Peripheral Arterial Surgery.溶栓与手术的随机对照研究。TOPAS研究组。溶栓或外周动脉手术。
J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):83S. doi: 10.1016/s1051-0443(95)71254-4.
4
Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost.下肢原发性动脉闭塞的溶栓治疗:临床疗效与成本
J Vasc Surg. 2001 Jun;33(6):1148-57. doi: 10.1067/mva.2001.114818.
5
Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity.非栓塞性下肢自体动脉闭塞的手术血管重建与溶栓治疗:一项前瞻性随机试验的结果。STILE研究组。下肢缺血的手术治疗与溶栓治疗。
J Vasc Surg. 1996 Oct;24(4):513-21; discussion 521-3. doi: 10.1016/s0741-5214(96)70067-8.
6
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.一项评估手术与溶栓治疗下肢缺血的前瞻性随机试验结果。STILE试验。
Ann Surg. 1994 Sep;220(3):251-66; discussion 266-8. doi: 10.1097/00000658-199409000-00003.
7
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.急性周围动脉缺血初始治疗中溶栓治疗与手术血管重建的比较。
J Vasc Surg. 1994 Jun;19(6):1021-30. doi: 10.1016/s0741-5214(94)70214-4.
8
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.重组尿激酶与血管手术作为腿部急性动脉闭塞初始治疗方法的比较。溶栓或外周动脉手术(TOPAS)研究人员。
N Engl J Med. 1998 Apr 16;338(16):1105-11. doi: 10.1056/NEJM199804163381603.
9
Intraarterial catheter thrombolytic therapy for acute peripheral arterial occlusions.急性周围动脉闭塞的动脉内导管溶栓治疗
Radiat Med. 1999 Jul-Aug;17(4):295-304.
10
Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.下肢搭桥移植血管闭塞的手术与溶栓前瞻性随机试验结果。
Am J Surg. 1996 Aug;172(2):105-12. doi: 10.1016/S0002-9610(96)00129-8.

引用本文的文献

1
Vascular Trauma in the Extremities: Factors Associated with the Outcome and Assessment of Amputation Indexes.肢体血管创伤:与截肢指数评估及预后相关的因素
Acta Cardiol Sin. 2022 Jul;38(4):455-463. doi: 10.6515/ACS.202207_38(4).20220128A.
2
Enhanced Angiogenesis by 11βHSD1 Blockage Is Insufficient to Improve Reperfusion Following Hindlimb Ischaemia.抑制11β-羟基类固醇脱氢酶1(11βHSD1)增强血管生成不足以改善后肢缺血后的再灌注。
Front Cardiovasc Med. 2022 Jan 12;8:795823. doi: 10.3389/fcvm.2021.795823. eCollection 2021.
3
Outcomes of Acute Limb Ischaemia in Patients with Underlying Malignancy: A Systematic Review.
合并潜在恶性肿瘤患者急性肢体缺血的结局:一项系统评价
EJVES Vasc Forum. 2021 Nov 5;54:13-20. doi: 10.1016/j.ejvsvf.2021.10.019. eCollection 2022.
4
Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes.口服抗凝药的使用和糖尿病不会抑制缺氧预处理的血液衍生分泌组的血管生成潜力。
Biomedicines. 2020 Aug 11;8(8):283. doi: 10.3390/biomedicines8080283.
5
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.亚太共识声明:外周动脉疾病管理:来自亚太动脉粥样硬化和血管疾病学会外周动脉疾病共识声明项目委员会的报告。
J Atheroscler Thromb. 2020 Aug 1;27(8):809-907. doi: 10.5551/jat.53660. Epub 2020 Jul 4.
6
Acute Limb Ischemia.急性肢体缺血
Ann Vasc Dis. 2018 Dec 25;11(4):443-448. doi: 10.3400/avd.ra.18-00074.
7
Surgery versus thrombolysis for initial management of acute limb ischaemia.手术与溶栓治疗急性肢体缺血的初始管理
Cochrane Database Syst Rev. 2018 Aug 10;8(8):CD002784. doi: 10.1002/14651858.CD002784.pub3.
8
Angiogenesis, Cancer, and Vascular Aging.血管生成、癌症与血管衰老
Front Cardiovasc Med. 2017 Oct 24;4:65. doi: 10.3389/fcvm.2017.00065. eCollection 2017.
9
Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease.嵌入生物启发构建体中的骨髓分离成年多谱系诱导细胞可促进外周血管疾病小鼠模型的恢复。
Biomed Mater. 2017 Feb 17;12(1):015024. doi: 10.1088/1748-605X/aa5a74.
10
Reconstituted high-density lipoproteins promote wound repair and blood flow recovery in response to ischemia in aged mice.重组高密度脂蛋白可促进老年小鼠缺血后伤口修复和血流恢复。
Lipids Health Dis. 2016 Sep 6;15(1):150. doi: 10.1186/s12944-016-0322-4.